Accelsiors CRO announce start of set-up and regulatory procedures for the Phase II Clinical Trial in Hepatitis C.
“After very positive feedback gained during the Phase Ib/IIa study, Accelsiors CRO is proud to announce the start of set-up and regulatory procedures for the subsequent Phase II Clinical Trial with the promising innovative compound used for the treatment of Hepatitis C,” said Desislava Simeonova MD, Head of Clinical Operations at Accelsiors CRO.
“This project brings together a group of companies with strong expertise and experience in Hepatitis C treatment,” said Emil Jakovljevic, Director, Study Set-up and Regulatory Compliance at Accelsiors CRO. “Accelsiors CRO, together with our partners on this project, is excited to work on the development path of such a promising compound for Hepatitis C treatment. Encouraged by the interim results of the Phase Ib/IIa study, we are looking forward with great expectations to the Phase II study we are currently preparing. We are also delighted to say that all of the investigators who are taking part in the currently still ongoing Phase Ib/IIa study showed high interest to continue their participation in the upcoming study phase. This is one additional indicator of the potentials this compound is showing and a clear sign of the needs for further innovative approaches in Hepatitis C treatment.”
Accelsiors CRO & Consultancy Services Ltd. is a midsized full service European Contract Research Organization, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. By combining our unique experience and expertise as well as our comprehensive capabilities across all areas of clinical drug development, we assist our clients to become successful drug developers. We have the operational flexibility to provide development services that perfectly match the demands of each of our clients, as part of an integrated “full service” solution. We specialize in the strategic planning, development, management and analysis of programs that support Clinical Development – from Phase I to marketing authorization and beyond.
Accelsiors is a synonym for Acceleration, Excellence & Achievements in clinical drug development. Every effort is made within Accelsiors to truly understand, accurately determine, clearly and consistently communicate and continuously satisfy the requirements of our clients in a manner which is efficient and effective to them whilst providing Accelsiors with the opportunity to grow and excel.
For further information please contact Accelsiors Communication Manager, Mr. Ferenc Erdos at F.Erdos@accelsiors.com.